Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Galveston, Texas 77555


Purpose:

The purpose of this study is to assess potential interactions between intravenous (IV) cocaine and 3 doses of GBR 12909.


Study summary:

This is Phase 1, double-blind, placebo-controlled human laboratory clinical pharmacology study that will assess the potential interactions between IV cocaine and 3 escalating oral doses of GBR 12909. The primary objective is to determine safety of GBR 12909 administration and if there are significant interactions between GBR 12909 treatment concurrent with IV cocaine infusions.


Criteria:

Inclusion Criteria: - Must be within 20% ideal body weight and must weigh at least 45 kg. - Must understand the study procedures and provide written informed consent. - Must meet DSM-4 criteria and are non-treatment seeking at time of study. Exclusion Criteria: - Please contact study site for more information


NCT ID:

NCT00100113


Primary Contact:

Principal Investigator
Kathryn Cunningham, Ph.D.
University of Texas Medical Branch - Galveston


Backup Contact:

N/A


Location Contact:

Galveston, Texas 77555
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: June 25, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.